Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zentalis Pharmaceuticals (ZNTL)
NASDAQ:ZNTL
RESEARCH TOOLSreports
Zentalis Pharmaceuticals (ZNTL) Ownership Overview
5.16% Insiders
28.15% Mutual Funds
45.97% Other Institutional Investors
8.67% ETFs
12.05% Public Companies and Individual Investors
The ownership structure of Zentalis Pharmaceuticals (ZNTL) stock is a mix of institutional, retail, and individual investors. Approximately 82.79% of the company’s stock is owned by Institutional Investors, 5.16% is owned by Insiders, and 12.05% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 12, 2025 | Ingmar Bruns Cmo | xxxxxxxxxxxxx | $45600 |
| Feb 05, 2025 | Mark Lackner Cso | xxxxxxxxxxxxx | $24569 |
| Feb 05, 2025 | Andrea Paul Clo | xxxxxxxxxxxxx | $22623 |
| Feb 05, 2025 | Vincent Vultaggio Pao And Interim Pfo | xxxxxxxxxxxxx | $4472 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $175576 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1607663 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $4607508 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,959,973 | Institution | 19.59% | 33,922,734 | |
| 8,532,904 | Institution | 11.97% | 20,734,957 | |
| 3,825,864 | Institution | 5.37% | 9,296,850 | |
| 2,952,234 | Institution | 4.14% | 7,173,929 | |
| 2,228,070 | Institution | 3.13% | 5,414,210 | |
| 1,520,630 | Institution | 2.13% | 3,695,131 | |
| 1,129,510 | Institution | 1.58% | 2,744,709 | |
| 1,070,784 | Insider | 1.50% | 2,602,005 | |
| 1,004,698 | Institution | 1.41% | 2,441,416 | |
| 688,103 | Institution | 0.97% | 1,672,090 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,532,904 | Institution | 11.97% | 20,734,957 | |
| 3,825,864 | Institution | 5.37% | 9,296,850 | |
| 1,129,510 | Institution | 1.58% | 2,744,709 | |
| 1,004,698 | Institution | 1.41% | 2,441,416 | |
| 688,103 | Institution | 0.97% | 1,672,090 | |
| 651,081 | Institution | 0.91% | 1,582,127 | |
| 640,666 | Institution | 0.90% | 1,556,818 | |
| 560,565 | Institution | 0.79% | 1,362,173 | |
| 525,137 | Institution | 0.74% | 1,276,083 | |
| 479,440 | Institution | 0.67% | 1,165,039 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,612,766 | Institution | 2.26% | 3,919,021 | |
| 1,579,228 | Institution | 2.22% | 4,785,061 | |
| 896,551 | Institution | 1.26% | 2,716,550 | |
| 525,102 | Institution | 0.74% | 1,275,998 | |
| 272,122 | Institution | 0.38% | 824,530 | |
| 264,640 | Institution | 0.37% | 643,075 | |
| 160,256 | Institution | 0.22% | 485,576 | |
| 154,007 | Institution | 0.22% | 374,237 | |
| 150,801 | Institution | 0.21% | 366,446 | |
| 76,096 | Institution | 0.11% | 184,913 |
FAQ
Who Owns Zentalis Pharmaceuticals (ZNTL)?
According to the latest TipRanks data, approximately 45.97% of the company's stock is held by institutional investors, 5.16% is held by insiders, and 12.05% is held by retail investors.
What percentage of Zentalis Pharmaceuticals (ZNTL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 45.97% of Zentalis Pharmaceuticals (ZNTL) stock is held by institutional investors.
What percentage of Zentalis Pharmaceuticals (ZNTL) stock is held by retail investors?
According to the latest TipRanks data, approximately 12.05% of Zentalis Pharmaceuticals (ZNTL) stock is held by retail investors.
Who owns the most shares of Zentalis Pharmaceuticals (ZNTL)?
Christopher J. Burke owns the most shares of Zentalis Pharmaceuticals (ZNTL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.